Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells

Journal of Experimental Medicine

Volumn 210, Issue 2, 2013, Pages 355-374

  Prete, Francesca ^a   Catucci, Marco ^b   Labrada, Mayrel ^a,c   Gobessi, Stefania ^a   Castiello, Maria Carmina ^b,d   Bonomi, Elisa ^e   Aiuti, Alessandro ^b,f   Vermi, William ^e,g   Cancrini, Caterina ^h   Metin, Ayse ⁱ   Hambleton, Sophie ^j   Bredius, Robbert ^k   Notarangelo, Luigi Daniele ^l   van der Burg, Mirjam ^m   Kalinke, Ulrich ⁿ   Villa, Anna ^b,o   Benvenuti, Federica ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^c CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

ⁱ Pediatric Hematology   (Turkey)

^j NEWCASTLE UNIVERSITY   (United Kingdom)

^k LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^l BOSTON CHILDREN S HOSPITAL   (United States)

^m ERASMUS MEDICAL CENTER   (Netherlands)

ⁿ HANNOVER MEDICAL SCHOOL   (Germany)

^o Milan Unit   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA INTERFERON; TOLL LIKE RECEPTOR 9; WISKOTT ALDRICH SYNDROME PROTEIN;

ACTIN POLYMERIZATION; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; GENE SILENCING; HEMATOPOIETIC CELL; IMMUNE DEFICIENCY; INNATE IMMUNITY; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RECURRENT INFECTION; SIGNAL TRANSDUCTION; WISKOTT ALDRICH SYNDROME;

ACTINS; ANIMALS; AUTOIMMUNITY; BASE SEQUENCE; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENDOCYTOSIS; FEMALE; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; INTERFERON-ALPHA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, INTERFERON ALPHA-BETA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 84874577141     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20120363     Document Type: Article

References (99)

1. Agrawal, H., N. Jacob, E. Carreras, S. Bajana, C. Putterman, S. Turner, B. Neas, A. Mathian, M.N. Koss, W. Stohl, et al. 2009. Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease. J. Immunol. 183:6021-6029. http://dx.doi.org/10.4049/jimmunol.0803872
2. Altfeld, M., L. Fadda, D. Frleta, and N. Bhardwaj. 2011. DCs and NK cells: critical effectors in the immune response to HIV-1. Nat. Rev. Immunol. 11:176-186. http://dx.doi.org/10.1038/nri2935
3. Andreansky, S., H. Liu, S. Turner, J.A. McCullers, R. Lang, R. Rutschman, P.C. Doherty, P.J. Murray, A.W. Nienhuis, and T.S. Strom. 2005. WASP- mice exhibit defective immune responses to influenza A virus, Streptococcus pneumoniae, and Mycobacterium bovis BCG. Exp. Hematol. 33:443-451. http://dx.doi.org/10.1016/j.exphem.2004.12.006
4. Astrakhan, A., H.D. Ochs, and D.J. Rawlings. 2009. Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells. J. Immunol. 182:7370-7380. http://dx.doi.org/10.4049/jimmunol.0804256
5. Badour, K., J. Zhang, F. Shi, M.K. McGavin, V. Rampersad, L.A. Hardy, D. Field, and K.A. Siminovitch. 2003. The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse. Immunity. 18: 141-154. http://dx.doi.org/10.1016/S1074-7613(02)00516-2
6. Baechler, E.C., F.M. Batliwalla, G. Karypis, P.M. Gaffney, W.A. Ortmann, K.J. Espe, K.B. Shark, W.J. Grande, K.M. Hughes, V. Kapur, et al. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA. 100:2610-2615. http://dx.doi.org/10.1073/pnas.0337679100
7. Baechler, E.C., J.W. Bauer, C.A. Slattery, W.A. Ortmann, K.J. Espe, J. Novitzke, S.R. Ytterberg, P.K. Gregersen, T.W. Behrens, and A.M. Reed. 2007. An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol. Med. 13:59- 68. http://dx.doi.org/10.2119/2006-00085.Baechler
8. Barrat, F.J., T. Meeker, J. Gregorio, J.H. Chan, S. Uematsu, S. Akira, B. Chang, O. Duramad, and R.L. Coffman. 2005. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202:1131-1139. http://dx.doi.org/10.1084/jem.20050914
9. Båve, U., G.V. Alm, and L. Rönnblom. 2000. The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer. J. Immunol. 165:3519-3526.
10. Båve, U., G. Nordmark, T. Lövgren, J. Rönnelid, S. Cajander, M.L. Eloranta, G.V. Alm, and L. Rönnblom. 2005. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum. 52:1185-1195. http://dx.doi.org/10.1002/art.20998
11. Becker-Herman, S., A. Meyer-Bahlburg, M.A. Schwartz, S.W. Jackson, K.L. Hudkins, C. Liu, B.D. Sather, S. Khim, D. Liggitt, W. Song, et al. 2011. WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity. J. Exp. Med. 208:2033-2042. http://dx.doi.org/10.1084/jem.20110200
12. Björck, P. 2004. Dendritic cells exposed to herpes simplex virus in vivo do not produce IFN-alpha after rechallenge with virus in vitro and exhibit decreased T cell alloreactivity. J. Immunol. 172:5396-5404.
13. Blanco, P., A.K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science. 294:1540-1543. http://dx.doi.org/10.1126/science.1064890
14. Blomberg, S., M.L. Eloranta, M. Magnusson, G.V. Alm, and L. Rönnblom. 2003. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum. 48:2524-2532. http://dx.doi.org/10.1002/art.11225
15. Bosticardo, M., F. Marangoni, A. Aiuti, A. Villa, and M. Grazia Roncarolo. 2009. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood. 113:6288-6295. http://dx.doi.org/10.1182/blood-2008-12-115253
16. Bosticardo, M., E. Draghici, F. Schena, A.V. Sauer, E. Fontana, M.C. Castiello, M. Catucci, M. Locci, L. Naldini, A. Aiuti, et al. 2011. Lentiviralmediated gene therapy leads to improvement of B-cell functionality in a murine model of Wiskott-Aldrich syndrome. J. Allergy Clin. Immunol. 127:1376-1384: e5. http://dx.doi.org/10.1016/j.jaci.2011.03.030
17. Bouma, G., A. Mendoza-Naranjo, M.P. Blundell, E. de Falco, K.L. Parsley, S.O. Burns, and A.J. Thrasher. 2011. Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming. Blood. 118:2492-2501. http://dx.doi.org/10.1182/blood-2011-03-340265
18. Cancro, M.P., D.P. D'Cruz, and M.A. Khamashta. 2009. The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus. J. Clin. Invest. 119:1066-1073. http://dx.doi.org/10.1172/JCI38010
19. Cao, H., J.D. Orth, J. Chen, S.G. Weller, J.E. Heuser, and M.A. McNiven. 2003. Cortactin is a component of clathrin-coated pits and participates in receptor-mediated endocytosis. Mol. Cell. Biol. 23:2162-2170. http://dx.doi.org/10.1128/MCB.23.6.2162-2170.2003
20. de Noronha, S., S. Hardy, J. Sinclair, M.P. Blundell, J. Strid, O. Schulz, J. Zwirner, G.E. Jones, D.R. Katz, C. Kinnon, and A.J. Thrasher. 2005. Impaired dendritic-cell homing in vivo in the absence of Wiskott- Aldrich syndrome protein. Blood. 105:1590-1597. http://dx.doi.org/10.1182/blood-2004-06-2332
21. Derivery, E., C. Sousa, J.J. Gautier, B. Lombard, D. Loew, and A. Gautreau. 2009. The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex. Dev. Cell. 17:712-723. http://dx.doi.org/10.1016/j.devcel.2009.09.010
22. Ding, D., H. Mehta, W.J. McCune, and M.J. Kaplan. 2006. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J. Immunol. 177:5878-5889.
23. Duan, X.Z., M. Wang, H.W. Li, H. Zhuang, D. Xu, and F.S. Wang. 2004. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J. Clin. Immunol. 24:637-646. http://dx.doi.org/10.1007/s10875-004-6249-y
24. Dupré, L., A. Aiuti, S. Trifari, S. Martino, P. Saracco, C. Bordignon, and M.G. Roncarolo. 2002. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity. 17:157-166. http://dx.doi.org/10.1016/S1074-7613(02)00360-6
25. Dupuis-Girod, S., J. Medioni, E. Haddad, P. Quartier, M. Cavazzana-Calvo, F. Le Deist, G. de Saint Basile, J. Delaunay, K. Schwarz, J.L. Casanova, et al. 2003. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 111:e622-e627. http://dx.doi.org/10.1542/peds.111.5.e622
26. Emamian, E.S., J.M. Leon, C.J. Lessard, M. Grandits, E.C. Baechler, P.M. Gaffney, B. Segal, N.L. Rhodus, and K.L. Moser. 2009. Peripheral blood gene expression profiling in Sjögren's syndrome. Genes Immun. 10:285-296. http://dx.doi.org/10.1038/gene.2009.20
27. Escoll, P., C. del Fresno, L. García, G. Vallés, M.J. Lendínez, F. Arnalich, and E. López-Collazo. 2003. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem. Biophys. Res. Commun. 311:465-472. http://dx.doi.org/10.1016/j.bbrc.2003.10.019
28. Fleck, M., E.R. Kern, T. Zhou, B. Lang, and J.D. Mountz. 1998. Murine cytomegalovirus induces a Sjögren's syndrome-like disease in C57Bl/6-lpr/lpr mice. Arthritis Rheum. 41:2175-2184. http://dx.doi.org/10.1002/1529-0131(199812)41:12<2175::AID-ART12>3.0.CO;2-I
29. Gallego, M.D., M.A. de la Fuente, I.M. Anton, S. Snapper, R. Fuhlbrigge, and R.S. Geha. 2006. WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1alpha. Int. Immunol. 18:221-232. http://dx.doi.org/10.1093/intimm/dxh310
30. Garcia-Romo, G.S., S. Caielli, B. Vega, J. Connolly, F. Allantaz, Z. Xu, M. Punaro, J. Baisch, C. Guiducci, R.L. Coffman, et al. 2011. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3:73ra20. http://dx.doi.org/10.1126/scitranslmed.3001201
31. Gilliet, M., and R. Lande. 2008. Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr. Opin. Immunol. 20:401-407. http://dx.doi.org/10.1016/j.coi.2008.06.008
32. Gilliet, M., W. Cao, and Y.J. Liu. 2008. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8:594-606. http://dx.doi.org/10.1038/nri2358
33. Gismondi, A., L. Cifaldi, C. Mazza, S. Giliani, S. Parolini, S. Morrone, J. Jacobelli, E. Bandiera, L. Notarangelo, and A. Santoni. 2004. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood. 104:436-443. http://dx.doi.org/10.1182/blood-2003-07-2621
34. Gottenberg, J.E., N. Cagnard, C. Lucchesi, F. Letourneur, S. Mistou, T. Lazure, S. Jacques, N. Ba, M. Ittah, C. Lepajolec, et al. 2006. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc. Natl. Acad. Sci. USA. 103:2770-2775. http://dx.doi.org/10.1073/pnas.0510837103
35. Guiducci, C., G. Ott, J.H. Chan, E. Damon, C. Calacsan, T. Matray, K.D. Lee, R.L. Coffman, and F.J. Barrat. 2006. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 203:1999-2008. http://dx.doi.org/10.1084/jem.20060401
36. Honda, K., Y. Ohba, H. Yanai, H. Negishi, T. Mizutani, A. Takaoka, C. Taya, and T. Taniguchi. 2005. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature. 434:1035-1040. http://dx.doi.org/10.1038/nature03547
37. Humblet-Baron, S., B. Sather, S. Anover, S. Becker-Herman, D.J. Kasprowicz, S. Khim, T. Nguyen, K. Hudkins-Loya, C.E. Alpers, S.F. Ziegler, et al. 2007. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J. Clin. Invest. 117:407-418. http://dx.doi.org/10.1172/JCI29539
38. Humphreys-Beher, M.G. 1996. Animal models for autoimmune diseaseassociated xerostomia and xerophthalmia. Adv. Dent. Res. 10:73-75. http://dx.doi.org/10.1177/08959374960100011501
39. Imai, K., T. Morio, Y. Zhu, Y. Jin, S. Itoh, M. Kajiwara, J. Yata, S. Mizutani, H.D. Ochs, and S. Nonoyama. 2004. Clinical course of patients with WASP gene mutations. Blood. 103:456-464. http://dx.doi.org/10.1182/blood-2003-05-1480
40. Ito, T., H. Kanzler, O. Duramad, W. Cao, and Y.J. Liu. 2006. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood. 107:2423-2431. http://dx.doi.org/10.1182/blood-2005-07-2709
41. Itoh, T., K.S. Erdmann, A. Roux, B. Habermann, H. Werner, and P. De Camilli. 2005. Dynamin and the actin cytoskeleton cooperatively regulate plasma membrane invagination by BAR and F-BAR proteins. Dev. Cell. 9:791-804. http://dx.doi.org/10.1016/j.devcel.2005.11.005
42. Jego, G., A.K. Palucka, J.P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau. 2003. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity. 19:225-234. http://dx.doi.org/10.1016/S1074-7613(03)00208-5
43. Jin, Y., C. Mazza, J.R. Christie, S. Giliani, M. Fiorini, P. Mella, F. Gandellini, D.M. Stewart, Q. Zhu, D.L. Nelson, et al. 2004. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 104:4010-4019. http://dx.doi.org/10.1182/blood-2003-05-1592
44. Kaksonen, M., C.P. Toret, and D.G. Drubin. 2005. A modular design for the clathrin-and actin-mediated endocytosis machinery. Cell. 123:305-320. http://dx.doi.org/10.1016/j.cell.2005.09.024
45. Kanto, T., M. Inoue, H. Miyatake, A. Sato, M. Sakakibara, T. Yakushijin, C. Oki, I. Itose, N. Hiramatsu, T. Takehara, et al. 2004. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J. Infect. Dis. 190:1919-1926. http://dx.doi.org/10.1086/425425
46. Kwok, S.K., J.Y. Lee, S.H. Park, M.L. Cho, S.Y. Min, S.H. Park, H.Y. Kim, and Y.G. Cho. 2008a. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus. Arthritis Res. Ther. 10:R29. http://dx.doi.org/10.1186/ar2382
47. Kwok, S.K., S.H. Seo, J.H. Ju, C.H. Yoon, S.C. Park, B.S. Kim, H.Y. Kim, and S.H. Park. 2008b. Cryptococcal meningitis presenting with isolated sixth cranial nerve palsy in a patient with systemic lupus erythematosus. J. Korean Med. Sci. 23:153-155. http://dx.doi.org/10.3346/jkms.2008.23.1.153
48. Lande, R., J. Gregorio, V. Facchinetti, B. Chatterjee, Y.H. Wang, B. Homey, W. Cao, Y.H. Wang, B. Su, F.O. Nestle, et al. 2007. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 449:564-569. http://dx.doi.org/10.1038/nature06116
49. Latz, E., A. Schoenemeyer, A. Visintin, K.A. Fitzgerald, B.G. Monks, C.F. Knetter, E. Lien, N.J. Nilsen, T. Espevik, and D.T. Golenbock. 2004. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5:190-198. http://dx.doi.org/10.1038/ni1028
50. Le Bon, A., V. Durand, E. Kamphuis, C. Thompson, S. Bulfone-Paus, C. Rossmann, U. Kalinke, and D.F. Tough. 2006a. Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during crosspriming. J. Immunol. 176:4682-4689.
51. Le Bon, A., C. Thompson, E. Kamphuis, V. Durand, C. Rossmann, U. Kalinke, and D.F. Tough. 2006b. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. 176:2074-2078.
52. Leverrier, Y., R. Lorenzi, M.P. Blundell, P. Brickell, C. Kinnon, A.J. Ridley, and A.J. Thrasher. 2001. Cutting edge: the Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells. J. Immunol. 166:4831-4834.
53. Litinskiy, M.B., B. Nardelli, D.M. Hilbert, B. He, A. Schaffer, P. Casali, and A. Cerutti. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3:822-829. http://dx.doi.org/10.1038/ni829
54. Locci, M., E. Draghici, F. Marangoni, M. Bosticardo, M. Catucci, A. Aiuti, C. Cancrini, L. Marodi, T. Espanol, R.G. Bredius, et al. 2009. The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function. J. Exp. Med. 206:735-742. http://dx.doi.org/10.1084/jem.20081773
55. Lorenzi, R., P.M. Brickell, D.R. Katz, C. Kinnon, and A.J. Thrasher. 2000. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood. 95:2943-2946.
56. Lövgren, T., M.L. Eloranta, U. Båve, G.V. Alm, and L. Rönnblom. 2004. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 50:1861-1872. http://dx.doi.org/10.1002/art.20254
57. Maillard, M.H., V. Cotta-de-Almeida, F. Takeshima, D.D. Nguyen, P. Michetti, C. Nagler, A.K. Bhan, and S.B. Snapper. 2007. The Wiskott-Aldrich syndrome protein is required for the function of CD4+CD25+Foxp3+ regulatory T cells. J. Exp. Med. 204:381-391. http://dx.doi.org/10.1084/jem.20061338
58. Marangoni, F., S. Trifari, S. Scaramuzza, C. Panaroni, S. Martino, L.D. Notarangelo, Z. Baz, A. Metin, F. Cattaneo, A. Villa, et al. 2007. WASP regulates suppressor activity of human and murine CD4+CD25+FOXP3+ natural regulatory T cells. J. Exp. Med. 204:369-380. http://dx.doi.org/10.1084/jem.20061334
59. Means, T.K., E. Latz, F. Hayashi, M.R. Murali, D.T. Golenbock, and A.D. Luster. 2005. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115:407-417.
60. Merrifield, C. J., D. Perrais, and D. Zenisek. 2005. Coupling between clathrin-coated-pit invagination, cortactin recruitment, and membrane scission observed in live cells. Cell. 121:593-606. http://dx.doi.org/10.1016/j.cell.2005.03.015
61. Meyer-Bahlburg, A., S. Becker-Herman, S. Humblet-Baron, S. Khim, M. Weber, G. Bouma, A.J. Thrasher, F.D. Batista, and D.J. Rawlings. 2008. Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis. Blood. 112:4158-4169. http://dx.doi.org/10.1182/blood-2008-02-140814
62. Migita, K., T. Miyashita, Y. Maeda, H. Kimura, M. Nakamura, H. Yatsuhashi, H. Ishibashi, and K. Eguchi. 2005. Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus. Clin. Exp. Immunol. 142:84-91. http://dx.doi.org/10.1111/j.1365-2249.2005.02897.x
63. Morales-Tirado, V., S. Johannson, E. Hanson, A. Howell, J. Zhang, K.A. Siminovitch, and D.J. Fowell. 2004. Cutting edge: selective requirement for the Wiskott-Aldrich syndrome protein in cytokine, but not chemokine, secretion by CD4+ T cells. J. Immunol. 173:726-730.
64. Murai, M., O. Turovskaya, G. Kim, R. Madan, C.L. Karp, H. Cheroutre, and M. Kronenberg. 2009. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 10:1178-1184. http://dx.doi.org/10.1038/ni.1791
65. Nestle, F.O., C. Conrad, A. Tun-Kyi, B. Homey, M. Gombert, O. Boyman, G. Burg, Y.J. Liu, and M. Gilliet. 2005. Plasmacytoid predendritic cells initiate psoriasis through interferon-? production. J. Exp. Med. 202:135-143. http://dx.doi.org/10.1084/jem.20050500
66. Nguyen, D.D., M.A. Wurbel, J.A. Goettel, M.A. Eston, O.S. Ahmed, R. Marin, E.K. Boden, E.J. Villablanca, H. Paidassi, V. Ahuja, et al. 2012. Wiskott-Aldrich syndrome protein deficiency in innate immune cells leads to mucosal immune dysregulation and colitis in mice. Gastroenterology. 143:719-729: e1-e2. http://dx.doi.org/10.1053/j.gastro.2012.06.008
67. Nikolov, N.P., M. Shimizu, S. Cleland, D. Bailey, J. Aoki, T. Strom, P.L. Schwartzberg, F. Candotti, and R.M. Siegel. 2010. Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein. Blood. 116:740-747. http://dx.doi.org/10.1182/blood-2009-08-237560
68. Ohashi, E., K. Tanabe, Y. Henmi, K. Mesaki, Y. Kobayashi, and K. Takei. 2011. Receptor sorting within endosomal trafficking pathway is facilitated by dynamic actin filaments. PLoS ONE. 6:e19942. http://dx.doi.org/10.1371/journal.pone.0019942
69. Orange, J.S., N. Ramesh, E. Remold-O'Donnell, Y. Sasahara, L. Koopman, M. Byrne, F.A. Bonilla, F.S. Rosen, R.S. Geha, and J.L. Strominger. 2002. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc. Natl. Acad. Sci. USA. 99:11351-11356. http://dx.doi.org/10.1073/pnas.162376099
70. Pascual, V., D. Chaussabel, and J. Banchereau. 2010. A genomic approach to human autoimmune diseases. Annu. Rev. Immunol. 28:535-571. http://dx.doi.org/10.1146/annurev-immunol-030409-101221
71. Pau, E., Y.H. Cheung, C. Loh, G. Lajoie, and J.E. Wither. 2012. TLR tolerance reduces IFN-alpha production despite plasmacytoid dendritic cell expansion and anti-nuclear antibodies in NZB bicongenic mice. PLoS ONE. 7:e36761. http://dx.doi.org/10.1371/journal.pone.0036761
72. Presicce, P., A. Taddeo, A. Conti, M.L. Villa, and S. Della Bella. 2008. Keyhole limpet hemocyanin induces the activation and maturation of human dendritic cells through the involvement of mannose receptor. Mol. Immunol. 45:1136-1145. http://dx.doi.org/10.1016/j.molimm.2007.07.020
73. Prinz, M., H. Schmidt, A. Mildner, K.P. Knobeloch, U.K. Hanisch, J. Raasch, D. Merkler, C. Detje, I. Gutcher, J. Mages, et al. 2008. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity. 28:675-686. http://dx.doi.org/10.1016/j.immuni.2008.03.011
74. Pulecio, J., E. Tagliani, A. Scholer, F. Prete, L. Fetler, O.R. Burrone, and F. Benvenuti. 2008. Expression of Wiskott-Aldrich syndrome protein in dendritic cells regulates synapse formation and activation of naive CD8+ T cells. J. Immunol. 181:1135-1142.
75. Recher, M., S.O. Burns, M.A. de la Fuente, S. Volpi, C. Dahlberg, J.E. Walter, K. Moffitt, D. Mathew, N. Honke, P.A. Lang, et al. 2012. B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice. Blood. 119:2819-2828. http://dx.doi.org/10.1182/blood-2011-09-379412
76. Sanjuan, M.A., N. Rao, K.T. Lai, Y. Gu, S. Sun, A. Fuchs, W.P. Fung-Leung, M. Colonna, and L. Karlsson. 2006. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J. Cell Biol. 172:1057-1068. http://dx.doi.org/10.1083/jcb.200508058
77. Santiago-Raber, M.L., R. Baccala, K.M. Haraldsson, D. Choubey, T.A. Stewart, D.H. Kono, and A.N. Theofilopoulos. 2003. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 197:777-788. http://dx.doi.org/10.1084/jem.20021996
78. Sasahara, Y., R. Rachid, M.J. Byrne, M.A. de la Fuente, R.T. Abraham, N. Ramesh, and R.S. Geha. 2002. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol. Cell. 10:1269-1281. http://dx.doi.org/10.1016/S1097-2765(02)00728-1
79. Sasai, M., and A. Iwasaki. 2011. Love triangle between Unc93B1, TLR7, and TLR9 prevents fatal attraction. Immunity. 35:3-5. http://dx.doi.org/10.1016/j.immuni.2011.07.006
80. Sasai, M., M.M. Linehan, and A. Iwasaki. 2010. Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science. 329:1530-1534. http://dx.doi.org/10.1126/science.1187029
81. Shimizu, M., N.P. Nikolov, K. Ueno, K. Ohta, R.M. Siegel, A. Yachie, and F. Candotti. 2012. Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency. Clin. Immunol. 142:160-166. http://dx.doi.org/10.1016/j.clim.2011.10.001
82. Sims, T.N., T.J. Soos, H.S. Xenias, B. Dubin-Thaler, J.M. Hofman, J.C. Waite, T.O. Cameron, V.K. Thomas, R. Varma, C.H. Wiggins, et al. 2007. Opposing effects of PKCtheta and WASp on symmetry breaking and relocation of the immunological synapse. Cell. 129:773-785. http://dx.doi.org/10.1016/j.cell.2007.03.037
83. Snapper, S.B., F.S. Rosen, E. Mizoguchi, P. Cohen, W. Khan, C.H. Liu, T.L. Hagemann, S.P. Kwan, R. Ferrini, L. Davidson, et al. 1998. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity. 9:81-91. http://dx.doi.org/10.1016/S1074-7613(00)80590-7
84. Snapper, S.B., P. Meelu, D. Nguyen, B.M. Stockton, P. Bozza, F.W. Alt, F.S. Rosen, U.H. von Andrian, and C. Klein. 2005. WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo. J. Leukoc. Biol. 77:993-998. http://dx.doi.org/10.1189/jlb.0804444
85. Strom, T.S., S.J. Turner, S. Andreansky, H. Liu, P.C. Doherty, D.K. Srivastava, J.M. Cunningham, and A.W. Nienhuis. 2003. Defects in Tcell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells. Blood. 102:3108-3116. http://dx.doi.org/10.1182/blood-2002-11-3489
86. Takenawa, T., and S. Suetsugu. 2007. The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat. Rev. Mol. Cell Biol. 8:37-48. http://dx.doi.org/10.1038/nrm2069
87. Thrasher, A.J., and S.O. Burns. 2010. WASP: a key immunological multitasker. Nat. Rev. Immunol. 10:182-192. http://dx.doi.org/10.1038/nri2724
88. Trifari, S., G. Sitia, A. Aiuti, S. Scaramuzza, F. Marangoni, L.G. Guidotti, S. Martino, P. Saracco, L.D. Notarangelo, M.G. Roncarolo, and L. Dupré. 2006. Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from Wiskott-Aldrich syndrome patients. J. Immunol. 177:7451-7461.
89. Trifari, S., S. Scaramuzza, M. Catucci, M. Ponzoni, L. Mollica, R. Chiesa, F. Cattaneo, F. Lafouresse, R. Calvez, W. Vermi, et al. 2010. Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs. J. Allergy Clin. Immunol. 125:439-448: e8. http://dx.doi.org/10.1016/j.jaci.2009.11.034
90. Tsuboi, S. 2007. Requirement for a complex of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein in podosome formation in macrophages. J. Immunol. 178:2987-2995.
91. Vallin, H., A. Perers, G.V. Alm, and L. Rönnblom. 1999. Anti-doublestranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J. Immunol. 163:6306-6313.
92. van Baarsen, L.G., C.L. Bos, T.C. van der Pouw Kraan, and C.L. Verweij. 2009. Transcription profiling of rheumatic diseases. Arthritis Res. Ther. 11:207. http://dx.doi.org/10.1186/ar2557
93. van der Pouw Kraan, T.C., C.A. Wijbrandts, L.G. van Baarsen, A.E. Voskuyl, F. Rustenburg, J.M. Baggen, S.M. Ibrahim, M. Fero, B.A. Dijkmans, P.P. Tak, and C.L. Verweij. 2007. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann. Rheum. Dis. 66:1008-1014. http://dx.doi.org/10.1136/ard.2006.063412
94. Vermi, W., L. Blanzuoli, M.D. Kraus, P. Grigolato, F. Donato, G. Loffredo, C.E. Marino, D. Alberti, L.D. Notarangelo, and F. Facchetti. 1999. The spleen in the Wiskott-Aldrich syndrome: histopathologic abnormalities of the white pulp correlate with the clinical phenotype of the disease. Am. J. Surg. Pathol. 23:182-191. http://dx.doi.org/10.1097/00000478-199902000-00007
95. Vermi, W., M. Soncini, L. Melocchi, S. Sozzani, and F. Facchetti. 2011. Plasmacytoid dendritic cells and cancer. J. Leukoc. Biol. 90:681-690. http://dx.doi.org/10.1189/jlb.0411190
96. Wengler, G.S., L.D. Notarangelo, S. Giliani, M.G. Pirastru, A.G. Ugazio, and O. Parolini. 1995. Mutation analysis in Wiskott Aldrich syndrome on chorionic villus DNA. Lancet. 346:641-642. http://dx.doi.org/10.1016/S0140-6736(95)91477-3
97. Westerberg, L., M. Larsson, S.J. Hardy, C. Fernández, A.J. Thrasher, and E. Severinson. 2005. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood. 105:1144-1152. http://dx.doi.org/10.1182/blood-2004-03-1003
98. Westerberg, L.S., M.A. de la Fuente, F. Wermeling, H.D. Ochs, M.C. Karlsson, S.B. Snapper, and L.D. Notarangelo. 2008. WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function. Blood. 112:4139-4147. http://dx.doi.org/10.1182/blood-2008-02-140715
99. Zhu, Q., C. Watanabe, T. Liu, D. Hollenbaugh, R.M. Blaese, S.B. Kanner, A. Aruffo, and H.D. Ochs. 1997. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood. 90:2680-2689.